Director/PDMR Shareholding
June 22 2022 - 2:00AM
Director/PDMR Shareholding
DXS INTERNATIONAL PLC
Notification of Change of Significant
Shareholding and PDMR Dealing
(“DXSP”)
The Board of DXS International plc (the
“Company”), the AQSE Growth Market quoted healthcare information
and clinical decision support systems provider, has been notified
that Mr Ron Rhodes has made transfers in relation to his entire
holding of 2,000,000 shares in the Company.
DL Services Limited, a company owned and
controlled by the Chief Executive’s wife, has acquired 845,000
Ordinary Shares in the Company at a price of 10p per share.
Following the transaction specified above Mr
Immelman’s interests, including those of persons closely associated
with him, is 5,720,501 Ordinary Shares representing 11.85% of the
issued share capital of the Company.
|
1 |
Details of the person discharging managerial
responsibilities / person closely associated |
|
a) |
Name |
DL Services Limited, a company owned and controlled by Lorraine
Immelman |
|
2 |
Reason for the notification |
|
a) |
Position/status |
Person closely associated with Chief Executive Officer David
Immelman |
|
b) |
Initial notification /Amendment |
Initial |
|
3 |
Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor |
|
a) |
Name |
DXS INTERNATIONAL PLC |
|
b) |
LEI |
2138001R1KEUWTXEVJ44 |
|
4 |
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted |
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of 0.33p each |
|
|
|
|
Identification code |
ISIN GB00B2Q6HZ92 |
|
|
|
|
b) |
Nature of the transaction |
Purchase |
|
c) |
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
10p |
845,000 |
|
|
|
|
|
|
|
|
d) |
Aggregated information |
|
|
|
|
|
- Aggregated volume |
|
|
|
|
|
- Price |
|
|
|
|
|
e) |
Date of the transaction |
6 June 2022 |
|
f) |
Place of the transaction |
Outside a trading venue |
The Directors of DXS International plc accept
responsibility for this announcement
Contacts:
| David
Immelman (Chief
Executive)DXS International plc |
01252 719800david@dxs-systems.com |
| |
|
|
www.dxs-systems.co.uk |
|
| Corporate
Advisor |
|
| City &
MerchantDavid Papworth |
020 7101 7676 |
| |
|
| Corporate
Broker |
|
| Hybridan
LLPClaire Louise Noyce |
020 3764 2341 |
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively which
should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jul 2023 to Jul 2024
